GMP defines how pharmaceutical systems maintain control. This guide explains how regulators evaluate GMP compliance, what inspection readiness looks like, and how control systems function in practice.

Audit systems function as independent verification within GMP. This guide explains how regulators evaluate audit effectiveness, findings, and inspection readiness.

A structured, inspection-focused guide to investigations and CAPA in pharmaceutical quality systems. Covers root cause analysis, lifecycle execution, governance, and how regulators assess effectiveness and recurrence.

A comprehensive, inspection-focused guide to Supplier Quality Management, covering qualification, governance, supplier oversight, and integration with GMP quality systems.

Documentation often fails during inspections due to how it is used and explained. This article outlines common documentation traps and how inspectors interpret them.

Correction practices influence inspection outcomes. This article explains how redlining and audit trails are assessed during GMP inspections.

Batch records are central to GMP inspections. This article explains how auditors review batch documentation and what common weaknesses raise concern.

FDA 483 observations frequently cite documentation failures. This article examines recurring documentation errors and how inspectors interpret them.

Good Documentation Practices ensure GMP records are reliable and inspection-ready. This article explains GDP principles with practical examples and inspection context.

GMP records are evidence of work performed. This article explains what inspectors expect from recording practices and why weak records undermine data integrity and compliance.

In GMP systems, documentation must be findable and explainable under inspection. This article explains how metadata and indexing affect searchability and compliance.

Selecting an eDMS is a governance decision, not just a technology choice. This article explains how inspectors assess eDMS use during GMP audits.